Sutro Biopharma
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.79 | 18.64 | 2.12 | 3.16 | 1.04 | 1.79 | 2.09 | 7.54 | 1.14 | 1.36 | 1.11 | 0.59 | 2.76 | |
| 0.07 | 0.28 | 0.29 | 0.22 | 0.22 | -0.21 | – | 0.22 | 0.22 | 0.19 | 0.10 | – | – | |
| 2.79 | 18.64 | 1.83 | 2.94 | 1.04 | 1.79 | 2.09 | 7.54 | 1.14 | 1.36 | 1.01 | 0.59 | 2.68 | |
| 7.54 | 8.81 | 9.25 | 7.64 | 7.57 | 8.61 | 6.21 | 4.53 | 4.70 | 4.27 | 2.79 | 1.91 | 8.73 | |
| 2.52 | 2.75 | 2.07 | 1.52 | 1.75 | 1.09 | 1.60 | 1.22 | 1.03 | 1.01 | 0.58 | 0.47 | 1.98 | |
| 10.06 | 11.57 | 11.04 | 8.94 | 9.32 | 9.70 | 10.34 | 7.93 | 6.85 | 5.28 | 3.28 | 2.40 | 11.23 | |
| -7.26 | 7.07 | -9.21 | -5.99 | -8.28 | -7.91 | -8.24 | -0.40 | -5.71 | -3.92 | -2.26 | -1.80 | -8.55 | |
| 1.43 | 1.43 | 1.53 | 1.11 | 0.96 | 1.05 | 1.28 | 1.14 | 1.23 | 1.20 | 0.72 | 0.60 | 2.42 | |
| -7.83 | 7.68 | -9.47 | -5.91 | -5.95 | -8.49 | -9.14 | -1.36 | -6.70 | -5.46 | -2.94 | -2.33 | -10.91 | |
| 0.30 | 2.59 | 0.28 | 0.00 | – | 0.29 | – | 0.00 | – | -0.01 | 0.00 | 0.00 | – | |
| -8.13 | 5.09 | -9.47 | -5.91 | -5.95 | -8.78 | -9.14 | -1.36 | -6.70 | -5.45 | -2.94 | -2.33 | -10.90 | |
| -6.11 | 9.40 | -8.02 | -4.79 | -4.76 | -7.21 | -5.48 | 0.13 | -5.25 | -4.06 | -2.12 | -1.65 | -8.12 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.